Clinical Outcome of Pericardial Closure Using Gentrix Following Cardiac Surgery

Sponsor
Methodist Health System (Other)
Overall Status
Recruiting
CT.gov ID
NCT06136182
Collaborator
(none)
489
2
12
244.5
20.3

Study Details

Study Description

Brief Summary

A descriptive comparative project will be conducted to determine if there is a difference in outcomes for adult patients requiring pericardial reconstruction using CorMatrix compared to Gentrix

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pericardial Closure Using Gentrix Following Cardiac Surgery

Detailed Description

A descriptive, comparative project will be conducted utilizing a retrospective chart review on patients at Methodist Mansfield Medical Center(MMMC) undergoing cardiac surgery requiring pericardial repair between the dates of January 1, 2017 through December 31, 2022. The project will compare outcomes of a pre- and post-intervention following use of Gentrix ECM and the CorMatrix Extracellular Matrix(ECM) pericardial patch using information gathered from the patient's electronic health record (EHR). The main outcome measures of post-operative Length of Stay(LOS), all-cause unplanned readmission within 30 days, and significant pleural effusion requiring thoracentesis within 30-days and 60 days as well as long-term (12 months) patient outcomes.

Study Design

Study Type:
Observational
Anticipated Enrollment :
489 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Clinical Outcome of Pericardial Closure Using Gentrix Following Cardiac Surgery
Actual Study Start Date :
May 12, 2023
Anticipated Primary Completion Date :
May 12, 2024
Anticipated Study Completion Date :
May 12, 2024

Outcome Measures

Primary Outcome Measures

  1. Post-operative hospital LOS [30 days]

    30-day all-cause unplanned readmissions after discharge Significant pleural effusion requiring thoracentesis within 30 days of surgery Significant pleural effusion requiring thoracentesis within 60 days of surgery

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Must have undergone a Coronary Artery Bypass Grafting(CABG) or valve repair/replacement surgery requiring pericardial reconstruction.

CABG or valve repair/replacement surgery must have been either elective or urgent status

Exclusion Criteria:

-CABG or valve repair/replacement surgery classified as emergent status Surgery classified as redo-sternotomy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinical Research Institute at Methodist Health System Dallas Texas United States 75203
2 Methodist Dallas Medical Center Dallas Texas United States 75203

Sponsors and Collaborators

  • Methodist Health System

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Methodist Health System
ClinicalTrials.gov Identifier:
NCT06136182
Other Study ID Numbers:
  • 016.SUR.2023.M
First Posted:
Nov 18, 2023
Last Update Posted:
Nov 18, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Nov 18, 2023